Navigation Links
Georgia Stem Cell Initiative meets on MCG campus Feb. 10
Date:2/3/2009

lker Boulevard near the R.A. Dent Boulevard intersection. Dr. Frank Treiber, MCG vice president for research development, will welcome participants at 10 a.m.

Speakers and topics include:

  • 10:05 a.m. - Dr. Robert K. Yu, director of the MCG Institute of Molecular Medicine and Science, Neuroscience Institute and Cord Blood bank, "Research Utilization of the MCG Cord Blood Bank."

  • 10:15 a.m. - Dr. David C. Hess, chair of the MCG Department of Neurology and co-director of the Brain & Behavior Discovery Institute, "Potential Clinical Applications of Stem Cells in Stroke Injury."

  • 10:30 a.m. - Dr. Charles S. Cox, pediatric surgeon and adjoint professor, Department of Biomedical Engineering, University of Texas-Houston Medical Center, "Progenitor Cell Therapy for Traumatic Brain Injury."

  • 11:15 a.m. - Dr. Anthony Ting, director of Regenerative Medicine, Athersys Inc., "Acute Myocardial Infarction Phase 1 Clinical Trial of Allogenic Stem Cells."

  • Noon - Faculty and students are encouraged to present posters on stem-cell related research during lunch. Posters will be displayed in the main hall of the first floor of the Health Sciences Building.

  • 1:30 p.m. Dr. Carlos M. Isales, director of the regenerative medicine program, MCG Institute of Molecular Medicine and Genetics, will give an overview of his program.

  • 1:45 p.m. - Dr. Steve Dalton, associate professor, biochemistry and molecular biology, UGA Center for Drug Discovery, "Multipotent Cardiovascular Progenitors."

  • 2:15 p.m. - Dr. Erhard Bieberich, biochemist in the MCG Schools of Medicine and Graduate Studies, "Smart Drugs for Smarter Stem Cells Using Sphingolipids to Enhance Stem Cell Differentiation."

  • 2:45 p.m. - Dr. Dave Machacek, researcher, UGA College of Agriculture and Environmental Sciences, "Development of Ion Channel and Ionotropic Receptor Expression in Human Embryonic Stem Cell Derived Neural Cultures."

    <
    '/>"/>


Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
2. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
3. Georgia Tech/Emory Center to study origin of life
4. Tropical crab invades Georgia oyster reefs -- but the long-term impact cant be predicted
5. Stanford launches $100 million initiative to tackle energy issues
6. EPA and USDA should create new initiative to better monitor nutrients
7. NAS announces initiative to connect entertainment industry with top experts
8. Latin American Science Initiative Puts Tropical Rainforest Diversity Online
9. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
10. NIHs Genes, Environment and Health Initiative adds 6 studies
11. Penn announces $50M Penn Integrates Knowledge neurosciences initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... . Why do ... to reproduce? And why are there two sexes anyway? These ... of the research journal Molecular Human Reproduction published ... Bielefeld University Bielefeld has compiled this special issue on sperm ... to copulate with several males in quick succession – chimpanzees ...
(Date:10/17/2014)... German . To ... treating overdoses, doctors are often limited to supportive therapy such ... a combination of drugs involved. So what can be done ... pills? ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical ... this question. "The task was to develop an agent that ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... raise questions about why such losses matter and why ... traditionally responded to such questions by citing societal benefits ... like controlling pests and diseases, promoting the productivity of ... many others. Nevertheless, many of these presumed benefits are ...
... Battery technology hasn,t kept pace with advancements in portable ... One revolutionary concept being pursued by a team of ... capable of converting movement from humans or found in ... variable capacitor generators known as "dielectric elastomer generators" (DEGs) ...
... Rochelle, NY, April 6, 2011 The successful ... survival and reduce the risk of neurological consequences ... the premier issue of Therapeutic Hypothermia and ... published by Mary Ann Liebert, Inc. This groundbreaking ...
Cached Biology News:Precedent-setting evidence of the benefits of biodiversity 2Precedent-setting evidence of the benefits of biodiversity 3Precedent-setting evidence of the benefits of biodiversity 4Replacing batteries may become a thing of the past, thanks to 'soft generators' 2Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest 2Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest 3
(Date:10/22/2014)... October 22, 2014 Grace Century, a ... healthcare projects, announces the addition of Dr. Yousef ... its advisory team. Dr. Siddiqui will provide further healthcare ... A graduate of University College Medical School ... in medicine in 2001. With further certification as a ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... DUBLIN , Oct. 22, 2014 ... "Organic Electronics Market by Material, by Application, Geography ... report to their offering. Organic electronics, ... a branch of material science which deals with small ... as organic because small molecules and polymers are carbon ...
Breaking Biology Technology:Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3
... OLIGOMERIX, Inc. today announced the receipt of a ... $323,000 from the National Institute on Aging of the ... program is to develop novel biomarker assays for Alzheimer,s ... apolipoprotein E (apoE) proteins will be monitored in cerebrospinal ...
... FRANCISCO, Feb. 25 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... Patent No. 7,495,024 entitled "Phenylalkyl N-Hydroxyureas for Combating Atherosclerotic ... for the treatment of atherosclerosis. This patent is ...
... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq:, SSRX ), ... manufacturing and marketing biopharmaceutical products, today,announced that it ... and,full year ended December 31, 2008 after the ... Following the earnings announcement, ...
Cached Biology Technology:OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer's Disease 2VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291 2VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291 3VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291 43SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009 2
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... Antibody Plate is a 96-well ELISA-compatible ... This antibody (mouse IgG 1 ) ... glutathione-S-transferase (GST), and binds with ... fusion protein in which the tag ...
... Testing Laboratory (RTL) can provide you ... years. ,,Microbial method development and validation ... the conditions of your GMP manufacturing ... products,,We offer a full spectrum of ...
... QED Bioscience has over 23 years of ... lines. We have made antibodies to large ... and viral antigens, and plasmid DNA-encoded antigens. ... is unique, so our hybridoma development programs ...
Biology Products: